Trial
What is being tested: Elritercept, a novel therapeutic agent, is being evaluated for its efficacy in reducing red blood cell (RBC) transfusion…
Clinical News
Personalised cancer vaccines have demonstrated efficacy in reducing recurrence risk in clinical trials, representing a significant advance in individualised cancer treatment approaches…
Clinical News
Cancer risk spans all demographics regardless of age, ethnicity, or background—screening and clinical vigilance should not be limited by patient assumptions about…
Clinical News
The Department of Health is withdrawing £1.5m funding from a haematology centre serving cancer patients in Belfast, creating significant financial jeopardy for…